Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 2
2008 1
2009 1
2010 1
2011 3
2012 3
2013 1
2014 1
2015 1
2020 0
Text availability
Article attribute
Article type
Publication date

Search Results

11 results
Results by year
Filters applied: . Clear all
Page 1
Multiple drug resistance-associated protein 4 (MRP4), prostaglandin transporter (PGT), and 15-hydroxyprostaglandin dehydrogenase (15-PGDH) as determinants of PGE2 levels in cancer.
Kochel TJ, Fulton AM. Kochel TJ, et al. Prostaglandins Other Lipid Mediat. 2015 Jan-Mar;116-117:99-103. doi: 10.1016/j.prostaglandins.2014.11.003. Epub 2014 Nov 27. Prostaglandins Other Lipid Mediat. 2015. PMID: 25433169 Free PMC article. Review.
Prostaglandin E2 EP receptors as therapeutic targets in breast cancer.
Reader J, Holt D, Fulton A. Reader J, et al. Cancer Metastasis Rev. 2011 Dec;30(3-4):449-63. doi: 10.1007/s10555-011-9303-2. Cancer Metastasis Rev. 2011. PMID: 22002714 Free PMC article. Review.
Targeting prostaglandin E EP receptors to inhibit metastasis.
Fulton AM, Ma X, Kundu N. Fulton AM, et al. Cancer Res. 2006 Oct 15;66(20):9794-7. doi: 10.1158/0008-5472.CAN-06-2067. Cancer Res. 2006. PMID: 17047037 Free article. Review.
Antimetastatic activity isolated from Colocasia esculenta (taro).
Kundu N, Campbell P, Hampton B, Lin CY, Ma X, Ambulos N, Zhao XF, Goloubeva O, Holt D, Fulton AM. Kundu N, et al. Anticancer Drugs. 2012 Feb;23(2):200-11. doi: 10.1097/CAD.0b013e32834b85e8. Anticancer Drugs. 2012. PMID: 21934603 Free PMC article.
A prostaglandin E (PGE) receptor EP4 antagonist protects natural killer cells from PGE2-mediated immunosuppression and inhibits breast cancer metastasis.
Ma X, Holt D, Kundu N, Reader J, Goloubeva O, Take Y, Fulton AM. Ma X, et al. Oncoimmunology. 2013 Jan 1;2(1):e22647. doi: 10.4161/onci.22647. Oncoimmunology. 2013. PMID: 23482441 Free PMC article.
Frondoside A inhibits breast cancer metastasis and antagonizes prostaglandin E receptors EP4 and EP2.
Ma X, Kundu N, Collin PD, Goloubeva O, Fulton AM. Ma X, et al. Breast Cancer Res Treat. 2012 Apr;132(3):1001-8. doi: 10.1007/s10549-011-1675-z. Epub 2011 Jul 15. Breast Cancer Res Treat. 2012. PMID: 21761157 Free PMC article.
Prostaglandin E receptor EP4 antagonism inhibits breast cancer metastasis.
Ma X, Kundu N, Rifat S, Walser T, Fulton AM. Ma X, et al. Cancer Res. 2006 Mar 15;66(6):2923-7. doi: 10.1158/0008-5472.CAN-05-4348. Cancer Res. 2006. PMID: 16540639 Free article.
Antagonism of the prostaglandin E receptor EP4 inhibits metastasis and enhances NK function.
Kundu N, Ma X, Holt D, Goloubeva O, Ostrand-Rosenberg S, Fulton AM. Kundu N, et al. Breast Cancer Res Treat. 2009 Sep;117(2):235-42. doi: 10.1007/s10549-008-0180-5. Epub 2008 Sep 16. Breast Cancer Res Treat. 2009. PMID: 18792778 Free PMC article.
Prostaglandin E(2) (PGE (2)) suppresses natural killer cell function primarily through the PGE(2) receptor EP4.
Holt D, Ma X, Kundu N, Fulton A. Holt D, et al. Cancer Immunol Immunother. 2011 Nov;60(11):1577-86. doi: 10.1007/s00262-011-1064-9. Epub 2011 Jun 17. Cancer Immunol Immunother. 2011. PMID: 21681369 Free PMC article.
11 results
Jump to page
Feedback